Panacea Innovation Ltd - 31 Dec 2024 SCHEDULE 13G/A Report for Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Venture Healthcare Fund II, L.P.
Security
Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
AMLX
Shares outstanding
84.6M shares
Disclosed Ownership
2.2M shares
Ownership
2.6%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:30:03 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 2.6% 2.2M 0 2.2M By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 2.6% 2.2M 0 2.2M By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 2.6% 2.2M 0 2.2M /s/ James Huang James Huang, Founding Managing Partner
James Huang 2.6% 2.2M 0 2.2M /s/ James Huang James Huang